VALHALLA, N.Y. -- New York Medical College of Valhalla has received a $1.6 million contract from the Biomedical Advanced Research and Development Authority for research to develop new influenza vaccines, U.S. Rep. Nita Lowey announced in a statement Tuesday.
The Biomedical Advanced Research and Development Authority is the federal program that facilitates the development of vaccines, drugs, therapies and diagnostic tools for public health emergencies.
The influenza vaccine development project led by Dr. Doris Bucher at New York Medical College seeks to "develop influenza vaccine seed strains optimized for high-production yields and high immunogenicity," according to a statement.
“As the senior Democrat on the House Appropriations Committee, my highest priority is investing in initiatives that sustain a high quality of life for families in the Lower Hudson Valley,” Lowey said in a statement. “This particular investment seeks to expedite and enlarge flu vaccine production, so that more and better vaccines are available quicker during high demand. This is a winning formula for strong communities, and I will continue my work in Congress to ensure support for scientific research.”
- 1 NYPD Detective Killed, Driver Injured In Wrong-Way Sprain Brook Crash
- 2 Mount Pleasant Will See Widespread Snow Sunday Into Monday
- 3 March Comes In Like A Lion As Latest Snowstorm Hits Mount Pleasant
- 4 Fatal Crash On Sprain Brook Parkway Snarls Morning Commute
- 5 Former NBA All-Star, New York Knicks Player Anthony Mason Dies At 48